Bluejay Diagnostics Inc (BJDX) is a Healthcare · Medical Devices company listed on NASDAQ. Price $0.92 (+8.88%), Market cap $0.00B, 52-week low–high $0.65 ~ $3.62.
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well
Financial statements, price targets, institutional (13F) holdings and related news for Bluejay Diagnostics Inc are updated in real time on BlackAll Trade.
Bluejay Diagnostics Inc trades at $0.92 (+8.88%). Real-time quotes and charts are available on BlackAll Trade.
Bluejay Diagnostics Inc has a market cap of about $0.00B.
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed